Altavalle, Italy

Alessandro Pojer

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: E-Pharma Trento S.p.a.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alessandro Pojer. Retrieved from https://idiyas.com/inventor/alessandro-pojer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alessandro Pojer

Introduction

Alessandro Pojer is a notable inventor based in Altavalle, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that address potential abuse of active ingredients. His work is characterized by a commitment to innovation and safety in medication.

Latest Patents

Pojer holds a patent for an "Abuse-proof solid pharmaceutical composition." This invention comprises an active ingredient with potential for abuse, silica in an amount ranging from 10 mg to 1000 mg, guar flour between 100 mg to 300 mg, and a water-soluble diluent from 500 mg to 5000 mg. This formulation aims to enhance the safety and efficacy of pharmaceutical products.

Career Highlights

Alessandro Pojer is associated with E-Pharma Trento S.p.a., where he continues to innovate in the pharmaceutical sector. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Pojer collaborates with talented professionals such as Silvia Boschetti and Massimiliano Rossi. Their combined expertise fosters a creative environment that drives forward-thinking solutions in pharmaceutical development.

Conclusion

Alessandro Pojer's contributions to the pharmaceutical industry exemplify the importance of innovation in creating safer medication options. His work not only addresses critical issues related to drug abuse but also enhances the overall quality of pharmaceutical compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…